EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ubiquitin-specific peptidase 25 ameliorates hepatic steatosis by stabilizing peroxisome proliferator-activated receptor alpha

Peihao Liu, Xin Song, Qingxia Chen, Li Cen, Chenxi Tang, Chaohui Yu, Chengfu Xu

Journal of Biological Chemistry · 2024-11 · 300 (11) · 107876

DOI: 10.1016/j.jbc.2024.107876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-11. Verfasst von Peihao Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Gastroenterolog…. Hauptthemen laut MEDLINE: PPAR alpha, Ubiquitin Thiolesterase, Non-alcoholic Fatty Liver Disease, Mice, Knockout. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. Ubiquitin-specific peptidase 25 (USP25) in adipocytes has been proven to be involved in insulin resistance, a noteworthy characteristic of NAFLD. However, the roles of USP25 in NAFLD remain unclear. In this study, we aimed to elucidate the role of USP25 in NAFLD. Hepatic USP25 protein levels were measured in NAFLD patients and models. USP25 expression was manipulated in both mice and cells to evaluate its role in NAFLD. A downstream target of USP25 in NAFLD progression was identified through proteomic profiling analyses and confirmed. Additionally, a USP25 inhibitor was used to determine whether USP25 could be a viable treatment target for NAFLD. We found that USP25 protein levels were significantly decreased in the livers of NAFLD patients and NAFLD model mice. USP25 protein levels were also decreased in both mouse primary hepatocytes and Huh7 cells treated with free fatty acids (FFAs). We also found that Usp25 knockout mice presented much more severe hepatic steatosis when they were fed a high-fat diet. Similarly, knocking down USP25 in Huh7 cell lines aggravated FFA-induced steatosis, whereas USP25 overexpression ameliorated FFA-induced steatosis in Huh7 cell lines. Further proteomic profiling revealed that the peroxisome proliferator-activated receptor alpha (PPARα) signaling pathway was a downstream target of USP25, which was confirmed in both mice and cell lines. Moreover, USP25 could stabilize PPARα by promoting its deubiquitination. Finally, a USP25 inhibitor exacerbated diet-induced steatosis in mice. In conclusion, USP25 may play a role in NAFLD through the PPARα signaling pathway and could be a potential therapeutic target for NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR alphaUbiquitin ThiolesteraseNon-alcoholic Fatty Liver DiseaseMice, KnockoutAnimalsHumansMiceMaleMice, Inbred C57BLHepatocytesProtein Stability

Stichwörter der Autor:innen

deubiquitinationhepatic steatosisnonalcoholic fatty liver diseaseperoxisome proliferator-activated receptor alphaubiquitin-specific peptidase 25

Substanzen

PPAR alphaUbiquitin ThiolesteraseUSP25 protein, humanPpara protein, mousePPARA protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, Westlake University Sc…
  • Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: zyyyych@zju.edu.cn.
  • Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: xiaofu@zju.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Zhejiang Province

Zitieren

APA

Liu, P., Song, X., Chen, Q., Cen, L., Tang, C., Yu, C., & Xu, C. (2024). Ubiquitin-specific peptidase 25 ameliorates hepatic steatosis by stabilizing peroxisome proliferator-activated receptor alpha. Journal of Biological Chemistry, 300(11), 107876. https://doi.org/10.1016/j.jbc.2024.107876

Vancouver

Liu P, Song X, Chen Q, Cen L, Tang C, Yu C, et al. Ubiquitin-specific peptidase 25 ameliorates hepatic steatosis by stabilizing peroxisome proliferator-activated receptor alpha. Journal of Biological Chemistry. 2024;300(11):107876. doi:10.1016/j.jbc.2024.107876

BibTeX
@article{Liu2024,
  author = {Liu, Peihao and Song, Xin and Chen, Qingxia and Cen, Li and Tang, Chenxi and Yu, Chaohui and Xu, Chengfu},
  title = {Ubiquitin-specific peptidase 25 ameliorates hepatic steatosis by stabilizing peroxisome proliferator-activated receptor alpha},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  volume = {300},
  number = {11},
  pages = {107876},
  doi = {10.1016/j.jbc.2024.107876}
}
Kostenlos starten →